Anticancer agent 122
Anticancer agent 122, an inhibitor of human lactate dehydrogenase A enzyme (hLDHA), has good anticancer activities and can be used for anticancer research[1].
Product Specifications
CAS Number
2924532-50-1
UNSPSC
12352005
Target
Lactate Dehydrogenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-122.html
Solubility
10 mM in DMSO
Smiles
O=C(OC)C/N=C1SC=C(C2=CC=CC=C2)N/1C3=CC=C(Cl)C=C3
Molecular Formula
C18H15ClN2O2S
Molecular Weight
358.84
References & Citations
[1]Sharma D, et.al.Design and Synthesis of Thiazole Scaffold-Based Small Molecules as Anticancer Agents Targeting the Human Lactate Dehydrogenase A Enzyme. ACS Omega. 2023 May 10;8 (20) :17552-17562.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
LDHA
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
134163-FITC 100 µL
TAC1 (NKA, NKNA, TAC2, Protachykinin-1, PPT, Substance P, Neurokinin A, Neuromedin L, Substance K, Neuropeptide K, Neuropeptide gamma, C-terminal-flanking Peptide) (FITC)
Sign In for Pricing
View Details 